The expression of SIGLEC9 was significantly elevated in colorectal cancer tissues, independent of mutations in the KRAS, NRAS, BRAF, PIK3CA, and AKT genes, as well as MSI status. This evidence concerns the gene SIGLEC9 and colorectal cancer.